Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

  • Nathan A. Berger
  • , Valerie C. Besson
  • , A. Hamid Boulares
  • , Alexander Bürkle
  • , Alberto Chiarugi
  • , Robert S. Clark
  • , Nicola J. Curtin
  • , Salvatore Cuzzocrea
  • , Ted M. Dawson
  • , Valina L. Dawson
  • , György Haskó
  • , Lucas Liaudet
  • , Flavio Moroni
  • , Pál Pacher
  • , Peter Radermacher
  • , Andrew L. Salzman
  • , Solomon H. Snyder
  • , Francisco Garcia Soriano
  • , Robert P. Strosznajder
  • , Balázs Sümegi
    • Raymond A. Swanson, Csaba Szabo

Research output: Contribution to journal › Review article › peer-review

185 Scopus citations

Fingerprint

Dive into the research topics of 'Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science